Literature DB >> 7786609

Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Office.

S S Burtles1, D R Newell, R E Henrar, T A Connors.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7786609     DOI： 10.1016/0959-8049(94)00483-l

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  8 in total

Review 1.  Modelling and simulation in the development and use of anti-cancer agents: an underused tool?

Authors:  Ferdinand Rombout; Leon Aarons; Mats Karlsson; Anthony Man; France Mentré; Peter Nygren; Amy Racine; Hans Schaefer; Jean-Louis Steimer; Iñaki Troconiz; Achiel van Peer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-12       Impact factor: 2.745

2.  Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β2-adrenergic receptor activation.

Authors:  Jason W-L Eng; Chelsey B Reed; Kathleen M Kokolus; Rosemarie Pitoniak; Adam Utley; Mark J Bucsek; Wen Wee Ma; Elizabeth A Repasky; Bonnie L Hylander
Journal:  Nat Commun       Date:  2015-03-10       Impact factor: 14.919

Review 3.  Murine models to evaluate novel and conventional therapeutic strategies for cancer.

Authors:  James E Talmadge; Rakesh K Singh; Isaiah J Fidler; Avraham Raz
Journal:  Am J Pathol       Date:  2007-03       Impact factor: 4.307

4.  United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).

Authors: 
Journal:  Br J Cancer       Date:  1998       Impact factor: 7.640

5.  Animal models and conserved processes.

Authors:  Ray Greek; Mark J Rice
Journal:  Theor Biol Med Model       Date:  2012-09-10       Impact factor: 2.432

6.  Cancer Research UK procedures in manufacture and toxicology of radiotracers intended for pre-phase I positron emission tomography studies in cancer patients.

Authors:  E O Aboagye; S K Luthra; F Brady; K Poole; H Anderson; T Jones; A Boobis; S S Burtles; P Price
Journal:  Br J Cancer       Date:  2002-04-08       Impact factor: 7.640

7.  Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics.

Authors:  D R Newell; S S Burtles; B W Fox; D I Jodrell; T A Connors
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

8.  Professor Tom Connors and the development of novel cancer therapies by the Phase I/II Clinical Trials Committee of Cancer Research UK.

Authors:  D R Newell; K M Searle; N B Westwood; S S Burtles
Journal:  Br J Cancer       Date:  2003-08-04       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.